John M. Strong

3.4k total citations
76 papers, 2.4k citations indexed

About

John M. Strong is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John M. Strong has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John M. Strong's work include Pharmacogenetics and Drug Metabolism (12 papers), Biochemical and Molecular Research (11 papers) and Pharmacological Effects and Toxicity Studies (11 papers). John M. Strong is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Biochemical and Molecular Research (11 papers) and Pharmacological Effects and Toxicity Studies (11 papers). John M. Strong collaborates with scholars based in United States, France and Malaysia. John M. Strong's co-authors include Arthur J. Atkinson, Woong‐Ku Lee, Jerry M. Collins, John S. Dutcher, Robert Parker, Lawrence W. Anderson, Shiew‐Mei Huang, Jeffrey L. Blumer, Samuel V. Lucas and K S Reynolds and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

John M. Strong

75 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. Strong United States	30	661	580	546	413	259	76	2.4k
Wayne A. Colburn United States	34	1.1k 1.7×	585 1.0×	577 1.1×	513 1.2×	182 0.7×	136	3.9k
B. Oosterhuis Netherlands	25	377 0.6×	426 0.7×	634 1.2×	370 0.9×	120 0.5×	74	2.1k
Dennis E. Drayer United States	29	554 0.8×	252 0.4×	525 1.0×	327 0.8×	474 1.8×	64	2.5k
Sven Björkman Sweden	40	691 1.0×	412 0.7×	377 0.7×	352 0.9×	150 0.6×	127	4.5k
Thorir D. Bjornsson United States	28	466 0.7×	470 0.8×	666 1.2×	244 0.6×	538 2.1×	72	2.8k
Denis J. Morgan Australia	28	295 0.4×	504 0.9×	589 1.1×	425 1.0×	187 0.7×	138	2.7k
Peter G. Dayton United States	32	702 1.1×	407 0.7×	587 1.1×	449 1.1×	169 0.7×	109	3.1k
Karl Zech Germany	30	636 1.0×	345 0.6×	475 0.9×	215 0.5×	103 0.4×	100	2.5k
David Lalka United States	23	339 0.5×	227 0.4×	341 0.6×	257 0.6×	267 1.0×	71	1.8k
Kenneth M. Piafsky Canada	15	385 0.6×	263 0.5×	351 0.6×	369 0.9×	145 0.6×	18	1.7k

Countries citing papers authored by John M. Strong

Since Specialization

Citations

This map shows the geographic impact of John M. Strong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Strong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Strong more than expected).

Fields of papers citing papers by John M. Strong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Strong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Strong. The network helps show where John M. Strong may publish in the future.

Co-authorship network of co-authors of John M. Strong

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Strong. A scholar is included among the top collaborators of John M. Strong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Strong. John M. Strong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Speranza, Giovanna, Martin Gutierrez, Shivaani Kummar, et al.. (2011). Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors. Cancer Chemotherapy and Pharmacology. 69(2). 431–438. 23 indexed citations

Zhao, Ping, Isabelle Ragueneau‐Majlessi, Lei Zhang, et al.. (2009). Quantitative Evaluation of Pharmacokinetic Inhibition of CYP3A Substrates by Ketoconazole: A Simulation Study. The Journal of Clinical Pharmacology. 49(3). 351–359. 70 indexed citations

Zhang, Lei, et al.. (2008). A regulatory viewpoint on transporter-based drug interactions. Xenobiotica. 38(7-8). 709–724. 140 indexed citations

Hartman, Neil R., et al.. (2002). Production of intracellular 35S-glutathione by rat and human hepatocytes for the quantification of xenobiotic reactive intermediates. Chemico-Biological Interactions. 142(1-2). 43–55. 13 indexed citations

Kapetanović, Izet M., John M. Strong, Wayne D. Yonekawa, et al.. (2002). Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro. Chemico-Biological Interactions. 142(1-2). 119–134. 29 indexed citations

Herman, Eugene H., James A. Vick, John M. Strong, et al.. (2001). Cardiovascular Effects of Buccal Exposure to Dermal Nicotine Patches in the Dog: A Comparative Evaluation. Journal of Toxicology Clinical Toxicology. 39(2). 135–142. 3 indexed citations

Kapetanović, Izet M., et al.. (1996). Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.. Drug Metabolism and Disposition. 24(9). 1002–1008. 28 indexed citations

Parker, Robert, Jerry M. Collins, & John M. Strong. (1996). Identification of 2,6-xylidine as a major lidocaine metabolite in human liver slices.. Drug Metabolism and Disposition. 24(11). 1167–1173. 41 indexed citations

Ludeman, Susan M., et al.. (1995). Oxime Derivatives of the Intermediary Oncostatic Metabolites of Cyclophosphamide and Ifosfamide: Synthesis and Deuterium Labeling for Applications to Metabolite Quantification. Journal of Pharmaceutical Sciences. 84(4). 393–398. 17 indexed citations

10.

Strong, John M., et al.. (1995). Similarity of metabolism for CAI (NSC 609974) in human liver tissue in vitro and in humans in vivo. PubMed. 1(4). 399–405. 11 indexed citations

11.

Anderson, Lawrence W., S. M. LUDEMAN, O. Michael Colvin, L B Grochow, & John M. Strong. (1995). Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood. Journal of Chromatography B Biomedical Sciences and Applications. 667(2). 247–257. 36 indexed citations

12.

Takimoto, Chris H., Raymond W. Klecker, William L. Dahut, et al.. (1994). Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 655(1). 97–104. 55 indexed citations

13.

Zaharevitz, Daniel, et al.. (1990). De novo synthesis of uracil nucleotides in mouse liver and intestine studied using [¹⁵N]alanine. European Journal of Biochemistry. 189(2). 437–440. 2 indexed citations

14.

Anderson, Lawrence W., John M. Strong, & Richard L. Cysyk. (1989). Cellular Pharmacology of DUP-785, a New Anticancer Agent. PubMed. 1(6). 381–387. 3 indexed citations

15.

Anderson, Lawrence W., Daniel Zaharevitz, & John M. Strong. (1987). Glutamine and glutamate: Automated quantification and isotopic enrichments by gas chromatography/mass spectrometry. Analytical Biochemistry. 163(2). 358–368. 34 indexed citations

16.

Klecker, Raymond W., Jean Jenkins, Timothy J. Kinsella, et al.. (1985). Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clinical Pharmacology & Therapeutics. 38(1). 45–51. 59 indexed citations

17.

Erlichman, Charles, John M. Strong, & Bruce A. Chabner. (1980). Application of a simple competitive protein-binding assay technique to the pharmacokinetics of N-(phosphonacetyl)-L-aspartate in humans.. PubMed. 40(6). 1902–6. 8 indexed citations

18.

Kapetanović, Izet M., John M. Strong, & John J. Mieyal. (1979). Metabolic structure-activity relationship for a homologous series of phenacetin analogs.. Journal of Pharmacology and Experimental Therapeutics. 209(1). 20–24. 8 indexed citations

19.

Erlichman, Charles, John M. Strong, Peter H. Wiernik, et al.. (1979). Phase I trial of N-(phosphonacetyl)-L-aspartate.. PubMed. 39(10). 3992–5. 16 indexed citations

20.

Strong, John M., et al.. (1974). Plasma levels of methsuximide and N‐desmethylmethsuximide during methsuximide therapy. Neurology. 24(3). 250–250. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact